Akademisyen
VOLKAN SEYRANTEPE
PROFESÖR
İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ FEN FAKÜLTESİ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 59
- Proje 0
- Kitap 0
- Bildiri 13
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
29
Q2
14
Q3
7
Q4
2
WoS (JCR)
Q1
20
Q2
16
Q3
10
Q4
4
TR Index
1
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
9
Ort. yüzdelik
71.6%
Üst %1 payı
0.0%
Üst %10 payı
23.1%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Intrathecal delivery of AAVrh10-mHexa combined with anti-inflammatory treatment reduces neuropathological markers and extends the lifespan of mice with early-onset Tay-Sachs disease YÖKSİS SJR Q2 JCR Q2 OpenAlex 15.5%
- 2025 A Comprehensive microRNA-seq Transcriptomic Analysis of Tay-Sachs Disease Mice Revealed Distinct miRNA Profiles in Neuroglial Cells YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.9%
- 2025 Imbalance in redox homeostasis is associated with neurodegeneration in the murine model of Tay-Sachs disease. YÖKSİS SJR Q2 JCR Q3 OpenAlex 86.9%
- 2025 Combined treatment of Ketogenic diet and propagermanium reduces neuroinflammation in Tay-Sachs disease mouse model. YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.9%
- 2025 Therapeutic targeting of neuroinflammation in sphingolipidosis YÖKSİS SJR Q2 JCR Q2 OpenAlex 14.4%
- 2025 Yeast-Produced Human Recombinant Lysosomal β-Hexosaminidase Efficiently Rescues GM2 Ganglioside Accumulation in Tay-Sachs Disease YÖKSİS SJR Q1 JCR Q1 OpenAlex 65.0%
- 2025 Mass spectrometric profiling reveals alterations in N-Glycans and O-Glycans in Tay-Sachs disease under Autophagy-Induced conditions YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.5%
- 2024 Abnormally accumulated GM2 ganglioside contributes to skeletal deformity in Tay-Sachs mice YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.5%
- 2024 Silencing of B4Galnt1 Gene Prevents GM2 Accumulation in Tay-Sachs Cells YÖKSİS OpenAlex 51.6%
- 2024 Induction of Exocytosis Rescues Lysosomal GM2 Accumulation in Tay-Sachs Disease YÖKSİS OpenAlex 60.5%
- 2024 Lithium treatment rescues dysfunctional autophagy in the cell models of Tay-Sachs disease. YÖKSİS SJR Q2 JCR Q2 OpenAlex 59.6%
- 2024 Gangliosides as Therapeutic Targets for Neurodegenerative Diseases YÖKSİS SJR Q4 JCR Q1 OpenAlex 85.1%
- 2023 Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.3%
- 2023 Molecular Trojan Horses for treating lysosomal storage diseases YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.1%
- 2022 Analysis of Brain Lipids in the Early-Onset Tay–Sachs Disease Mouse Model With the Combined Deficiency of β-Hexosaminidase A and Neuraminidase 3 YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.6%
- 2021 Sialidase neu4 deficiency is associated with neuroinflammation in mice YÖKSİS SJR Q3 JCR Q3 OpenAlex 53.1%
- 2020 GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease YÖKSİS OpenAlex üst %10 OpenAlex 90.3%
- 2018 Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.0%
- 2018 Identification of cytoplasmic sialidase NEU2-associated proteins by LC-MS/MS YÖKSİS SJR Q3 JCR Q4 OpenAlex 44.4%
- 2018 The Second Case of Saposin A Deficiency and Altered Autophagy YÖKSİS SJR Q3 OpenAlex üst %10 OpenAlex 91.8%